3.26.1 html 255 414 1 true 89 0 false 8 false false R1.htm 75000 - Document - Document and Entity Information Sheet http://lbpharma.us/20251231/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 75010 - Statement - Balance Sheets Sheet http://lbpharma.us/20251231/taxonomy/role/StatementBalanceSheets Balance Sheets Statements 2 false false R3.htm 75020 - Statement - Balance Sheets (Parenthetical) Sheet http://lbpharma.us/20251231/taxonomy/role/StatementBalanceSheetsParenthetical Balance Sheets (Parenthetical) Statements 3 false false R4.htm 75030 - Statement - Statements of Operations Sheet http://lbpharma.us/20251231/taxonomy/role/StatementStatementsOfOperations Statements of Operations Statements 4 false false R5.htm 75040 - Statement - Statements of Comprehensive Loss Sheet http://lbpharma.us/20251231/taxonomy/role/StatementStatementsOfComprehensiveLoss Statements of Comprehensive Loss Statements 5 false false R6.htm 75050 - Statement - Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) Sheet http://lbpharma.us/20251231/taxonomy/role/StatementStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) Statements 6 false false R7.htm 75060 - Statement - Statements of Cash Flows Sheet http://lbpharma.us/20251231/taxonomy/role/StatementStatementsOfCashFlows Statements of Cash Flows Statements 7 false false R8.htm 75070 - Statement - Statements of Cash Flows (Parenthetical) Sheet http://lbpharma.us/20251231/taxonomy/role/StatementStatementsOfCashFlowsParenthetical Statements of Cash Flows (Parenthetical) Statements 8 false false R9.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 9 false false R10.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 10 false false R11.htm 995447 - Disclosure - Insider Trading Policies and Procedures Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc Insider Trading Policies and Procedures Notes 11 false false R12.htm 995457 - Disclosure - Cybersecurity Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureCybersecurity Cybersecurity Notes 12 false false R13.htm 995467 - Disclosure - Business Overview Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureBusinessOverview Business Overview Notes 13 false false R14.htm 995477 - Disclosure - Summary of Significant Accounting Policies Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 14 false false R15.htm 995487 - Disclosure - Fair Value Measurements Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 15 false false R16.htm 995497 - Disclosure - Cash Equivalents, Marketable Securities and Restricted Cash Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureCashEquivalentsMarketableSecuritiesAndRestrictedCash Cash Equivalents, Marketable Securities and Restricted Cash Notes 16 false false R17.htm 995507 - Disclosure - Property and Equipment, Net Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNet Property and Equipment, Net Notes 17 false false R18.htm 995517 - Disclosure - Prepaid Expenses and Other Current Assets and Accrued Expenses Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsAndAccruedExpenses Prepaid Expenses and Other Current Assets and Accrued Expenses Notes 18 false false R19.htm 995527 - Disclosure - Leases Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureLeases Leases Notes 19 false false R20.htm 995537 - Disclosure - Redeemable Convertible Preferred Stock and Equity Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAndEquity Redeemable Convertible Preferred Stock and Equity Notes 20 false false R21.htm 995547 - Disclosure - Net Loss per Share Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureNetLossPerShare Net Loss per Share Notes 21 false false R22.htm 995557 - Disclosure - Stock-Based Compensation Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureStockbasedCompensation Stock-Based Compensation Notes 22 false false R23.htm 995567 - Disclosure - Restructuring Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureRestructuring Restructuring Notes 23 false false R24.htm 995577 - Disclosure - Income Taxes Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureIncomeTaxes Income Taxes Notes 24 false false R25.htm 995587 - Disclosure - Commitments and Contingencies Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 25 false false R26.htm 995597 - Disclosure - Related-Party Transactions Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureRelatedpartyTransactions Related-Party Transactions Notes 26 false false R27.htm 995607 - Disclosure - Subsequent Events Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureSubsequentEvents Subsequent Events Notes 27 false false R28.htm 995617 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://lbpharma.us/20251231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies 28 false false R29.htm 995627 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://lbpharma.us/20251231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies 29 false false R30.htm 995637 - Disclosure - Fair Value Measurements (Tables) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://lbpharma.us/20251231/taxonomy/role/DisclosureFairValueMeasurements 30 false false R31.htm 995647 - Disclosure - Cash Equivalents, Marketable Securities and Restricted Cash (Tables) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureCashEquivalentsMarketableSecuritiesAndRestrictedCashTables Cash Equivalents, Marketable Securities and Restricted Cash (Tables) Tables http://lbpharma.us/20251231/taxonomy/role/DisclosureCashEquivalentsMarketableSecuritiesAndRestrictedCash 31 false false R32.htm 995657 - Disclosure - Property and Equipment, Net (Tables) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetTables Property and Equipment, Net (Tables) Tables http://lbpharma.us/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNet 32 false false R33.htm 995667 - Disclosure - Prepaid Expenses and Other Current Assets and Accrued Expenses (Tables) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsAndAccruedExpensesTables Prepaid Expenses and Other Current Assets and Accrued Expenses (Tables) Tables http://lbpharma.us/20251231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsAndAccruedExpenses 33 false false R34.htm 995677 - Disclosure - Leases (Tables) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureLeasesTables Leases (Tables) Tables http://lbpharma.us/20251231/taxonomy/role/DisclosureLeases 34 false false R35.htm 995687 - Disclosure - Redeemable Convertible Preferred Stock and Equity (Tables) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAndEquityTables Redeemable Convertible Preferred Stock and Equity (Tables) Tables http://lbpharma.us/20251231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAndEquity 35 false false R36.htm 995697 - Disclosure - Net Loss per Share (Tables) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureNetLossPerShareTables Net Loss per Share (Tables) Tables http://lbpharma.us/20251231/taxonomy/role/DisclosureNetLossPerShare 36 false false R37.htm 995707 - Disclosure - Stock-Based Compensation (Tables) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureStockbasedCompensationTables Stock-Based Compensation (Tables) Tables http://lbpharma.us/20251231/taxonomy/role/DisclosureStockbasedCompensation 37 false false R38.htm 995717 - Disclosure - Restructuring (Tables) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureRestructuringTables Restructuring (Tables) Tables http://lbpharma.us/20251231/taxonomy/role/DisclosureRestructuring 38 false false R39.htm 995727 - Disclosure - Income Taxes (Tables) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureIncomeTaxesTables Income Taxes (Tables) Tables http://lbpharma.us/20251231/taxonomy/role/DisclosureIncomeTaxes 39 false false R40.htm 995737 - Disclosure - Business Overview - Additional Information (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureBusinessOverviewAdditionalInformationDetails Business Overview - Additional Information (Details) Details 40 false false R41.htm 995747 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails Summary of Significant Accounting Policies - Additional Information (Details) Details 41 false false R42.htm 995757 - Disclosure - Summary of Significant Accounting Policies - Schedule of Reconciliation of the Company's net loss (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfReconciliationOfTheCompanysNetLossDetails Summary of Significant Accounting Policies - Schedule of Reconciliation of the Company's net loss (Details) Details 42 false false R43.htm 995767 - Disclosure - Summary of Significant Accounting Policies - Depreciation of Property and Equipment Estimated Useful Lives (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesDepreciationOfPropertyAndEquipmentEstimatedUsefulLivesDetails Summary of Significant Accounting Policies - Depreciation of Property and Equipment Estimated Useful Lives (Details) Details 43 false false R44.htm 995777 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Details 44 false false R45.htm 995787 - Disclosure - Fair Value Measurements - Additional Information (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails Fair Value Measurements - Additional Information (Details) Details 45 false false R46.htm 995797 - Disclosure - Fair Value Measurements - Schedule of Assumptions Used in Estimating Fair Value of Derivative Liabilities for Warrant Liabilities (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfAssumptionsUsedInEstimatingFairValueOfDerivativeLiabilitiesForWarrantLiabilitiesDetails Fair Value Measurements - Schedule of Assumptions Used in Estimating Fair Value of Derivative Liabilities for Warrant Liabilities (Details) Details 46 false false R47.htm 995807 - Disclosure - Fair Value Measurements - Schedule of Change in the Derivative Liabilities (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfChangeInTheDerivativeLiabilitiesDetails Fair Value Measurements - Schedule of Change in the Derivative Liabilities (Details) Details 47 false false R48.htm 995817 - Disclosure - Cash Equivalents, Marketable Securities and Restricted Cash - Schedule of Cash Equivalents and Marketable Securities (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureCashEquivalentsMarketableSecuritiesAndRestrictedCashScheduleOfCashEquivalentsAndMarketableSecuritiesDetails Cash Equivalents, Marketable Securities and Restricted Cash - Schedule of Cash Equivalents and Marketable Securities (Details) Details 48 false false R49.htm 995827 - Disclosure - Cash Equivalents, Marketable Securities and Restricted Cash - Schedule of Contractual Maturities of the Company's Marketable Securities (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureCashEquivalentsMarketableSecuritiesAndRestrictedCashScheduleOfContractualMaturitiesOfTheCompanysMarketableSecuritiesDetails Cash Equivalents, Marketable Securities and Restricted Cash - Schedule of Contractual Maturities of the Company's Marketable Securities (Details) Details 49 false false R50.htm 995837 - Disclosure - Cash Equivalents, Marketable Securities and Restricted Cash - Additional Information (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureCashEquivalentsMarketableSecuritiesAndRestrictedCashAdditionalInformationDetails Cash Equivalents, Marketable Securities and Restricted Cash - Additional Information (Details) Details 50 false false R51.htm 995847 - Disclosure - Cash Equivalents, Marketable Securities and Restricted Cash - Schedule of Cash Equivalents and Restricted Cash (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureCashEquivalentsMarketableSecuritiesAndRestrictedCashScheduleOfCashEquivalentsAndRestrictedCashDetails Cash Equivalents, Marketable Securities and Restricted Cash - Schedule of Cash Equivalents and Restricted Cash (Details) Details 51 false false R52.htm 995857 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment, Net (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails Property and Equipment, Net - Schedule of Property and Equipment, Net (Details) Details 52 false false R53.htm 995867 - Disclosure - Property and Equipment, Net (Additional Information) (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetails Property and Equipment, Net (Additional Information) (Details) Details http://lbpharma.us/20251231/taxonomy/role/DisclosurePropertyAndEquipmentNetTables 53 false false R54.htm 995877 - Disclosure - Prepaid Expenses and Other Current Assets and Accrued Expenses - Schedule of Prepaid Expenses (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsAndAccruedExpensesScheduleOfPrepaidExpensesDetails Prepaid Expenses and Other Current Assets and Accrued Expenses - Schedule of Prepaid Expenses (Details) Details 54 false false R55.htm 995887 - Disclosure - Prepaid Expenses and Other Current Assets and Accrued Expenses - Schedule of Accrued Expenses (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsAndAccruedExpensesScheduleOfAccruedExpensesDetails Prepaid Expenses and Other Current Assets and Accrued Expenses - Schedule of Accrued Expenses (Details) Details 55 false false R56.htm 995897 - Disclosure - Prepaid Expenses and Other Current Assets and Accrued Expenses - Additional Information (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosurePrepaidExpensesAndOtherCurrentAssetsAndAccruedExpensesAdditionalInformationDetails Prepaid Expenses and Other Current Assets and Accrued Expenses - Additional Information (Details) Details 56 false false R57.htm 995907 - Disclosure - Leases - Additional Information (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureLeasesAdditionalInformationDetails Leases - Additional Information (Details) Details 57 false false R58.htm 995917 - Disclosure - Leases - Summary of Components of Lease Expense (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureLeasesSummaryOfComponentsOfLeaseExpenseDetails Leases - Summary of Components of Lease Expense (Details) Details 58 false false R59.htm 995927 - Disclosure - Leases - Summary of Supplemental Balance Sheet Information Related to Operating Leases (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureLeasesSummaryOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesDetails Leases - Summary of Supplemental Balance Sheet Information Related to Operating Leases (Details) Details 59 false false R60.htm 995937 - Disclosure - Leases - Summary of Other Information Related to Leases (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureLeasesSummaryOfOtherInformationRelatedToLeasesDetails Leases - Summary of Other Information Related to Leases (Details) Details 60 false false R61.htm 995947 - Disclosure - Leases - Summary of Future Minimum Commitments Under operating Leases (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureLeasesSummaryOfFutureMinimumCommitmentsUnderOperatingLeasesDetails Leases - Summary of Future Minimum Commitments Under operating Leases (Details) Details 61 false false R62.htm 995967 - Disclosure - Leases - Summary of Future Minimum Commitments Under operating Leases (Parenthetical) (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureLeasesSummaryOfFutureMinimumCommitmentsUnderOperatingLeasesParentheticalDetails Leases - Summary of Future Minimum Commitments Under operating Leases (Parenthetical) (Details) Details 62 false false R63.htm 995977 - Disclosure - Redeemable Convertible Preferred Stock and Equity - Schedule of Redeemable Convertible Preferred Stock (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAndEquityScheduleOfRedeemableConvertiblePreferredStockDetails Redeemable Convertible Preferred Stock and Equity - Schedule of Redeemable Convertible Preferred Stock (Details) Details 63 false false R64.htm 995987 - Disclosure - Redeemable Convertible Preferred Stock and Equity - Schedule of Warrants Outstanding (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAndEquityScheduleOfWarrantsOutstandingDetails Redeemable Convertible Preferred Stock and Equity - Schedule of Warrants Outstanding (Details) Details 64 false false R65.htm 995997 - Disclosure - Redeemable Convertible Preferred Stock and Equity - Additional Information (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAndEquityAdditionalInformationDetails Redeemable Convertible Preferred Stock and Equity - Additional Information (Details) Details 65 false false R66.htm 996007 - Disclosure - Net Loss per Share - Schedule of Computation of Basic and Diluted Net Loss per Share of Common Stock (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedNetLossPerShareOfCommonStockDetails Net Loss per Share - Schedule of Computation of Basic and Diluted Net Loss per Share of Common Stock (Details) Details 66 false false R67.htm 996017 - Disclosure - Net Loss per Share - Schedule of Computation of Basic and Diluted Net Loss per Share of Common Stock (Parenthetical) (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedNetLossPerShareOfCommonStockParentheticalDetails Net Loss per Share - Schedule of Computation of Basic and Diluted Net Loss per Share of Common Stock (Parenthetical) (Details) Details 67 false false R68.htm 996027 - Disclosure - Net Loss per Share - Schedule of Potentially Dilutive Shares Excluded From Calculation of Diluted Net Loss Per Share (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureNetLossPerShareScheduleOfPotentiallyDilutiveSharesExcludedFromCalculationOfDilutedNetLossPerShareDetails Net Loss per Share - Schedule of Potentially Dilutive Shares Excluded From Calculation of Diluted Net Loss Per Share (Details) Details 68 false false R69.htm 996037 - Disclosure - Stock-Based Compensation - Additional Information (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureStockbasedCompensationAdditionalInformationDetails Stock-Based Compensation - Additional Information (Details) Details 69 false false R70.htm 996047 - Disclosure - Stock-Based Compensation - Schedule of Assumptions used in Estimating Fair Value of Stock Options (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfAssumptionsUsedInEstimatingFairValueOfStockOptionsDetails Stock-Based Compensation - Schedule of Assumptions used in Estimating Fair Value of Stock Options (Details) Details 70 false false R71.htm 996057 - Disclosure - Stock-Based Compensation - Summary of company's Stock Option Activity (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfCompanysStockOptionActivityDetails Stock-Based Compensation - Summary of company's Stock Option Activity (Details) Details 71 false false R72.htm 996067 - Disclosure - Stock-Based Compensation - Summary of the Company's restricted stock activity (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfTheCompanysRestrictedStockActivityDetails Stock-Based Compensation - Summary of the Company's restricted stock activity (Details) Details 72 false false R73.htm 996077 - Disclosure - Stock-Based Compensation - Schedule of stock-based compensation (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureStockbasedCompensationScheduleOfStockbasedCompensationDetails Stock-Based Compensation - Schedule of stock-based compensation (Details) Details 73 false false R74.htm 996087 - Disclosure - Restructuring - Additional Information (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureRestructuringAdditionalInformationDetails Restructuring - Additional Information (Details) Details 74 false false R75.htm 996097 - Disclosure - Restructuring - Schedule of Reconciliation of Beginning and Ending Liability Balances (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureRestructuringScheduleOfReconciliationOfBeginningAndEndingLiabilityBalancesDetails Restructuring - Schedule of Reconciliation of Beginning and Ending Liability Balances (Details) Details 75 false false R76.htm 996107 - Disclosure - Income Taxes - Schedule of Provision for Income Taxes (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureIncomeTaxesScheduleOfProvisionForIncomeTaxesDetails Income Taxes - Schedule of Provision for Income Taxes (Details) Details 76 false false R77.htm 996117 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureIncomeTaxesScheduleOfEffectiveIncomeTaxRateReconciliationDetails Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) Details 77 false false R78.htm 996127 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureIncomeTaxesScheduleOfDeferredTaxAssetsAndLiabilitiesDetails Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) Details 78 false false R79.htm 996137 - Disclosure - Income Taxes - Additional Information (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails Income Taxes - Additional Information (Details) Details 79 false false R80.htm 996147 - Disclosure - Commitments and Contingencies - Additional Information (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails Commitments and Contingencies - Additional Information (Details) Details 80 false false R81.htm 996157 - Disclosure - Related-Party Transactions - Additional Information (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureRelatedpartyTransactionsAdditionalInformationDetails Related-Party Transactions - Additional Information (Details) Details 81 false false R82.htm 996167 - Disclosure - Subsequent Events - Additional Information (Details) Sheet http://lbpharma.us/20251231/taxonomy/role/DisclosureSubsequentEventsAdditionalInformationDetails Subsequent Events - Additional Information (Details) Details 82 false false All Reports Book All Reports lbrx-20251231.htm lbrx-20251231.xsd img120373924_0.jpg img120373924_1.jpg img120373924_10.jpg img120373924_11.jpg img120373924_12.jpg img120373924_13.jpg img120373924_14.jpg img120373924_15.jpg img120373924_16.jpg img120373924_17.jpg img120373924_18.jpg img120373924_19.jpg img120373924_2.jpg img120373924_20.jpg img120373924_21.jpg img120373924_22.jpg img120373924_23.jpg img120373924_24.jpg img120373924_25.jpg img120373924_26.jpg img120373924_27.jpg img120373924_28.jpg img120373924_29.jpg img120373924_3.jpg img120373924_30.jpg img120373924_31.jpg img120373924_4.jpg img120373924_5.jpg img120373924_6.jpg img120373924_7.jpg img120373924_8.jpg img120373924_9.jpg http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/cyd/2025 http://xbrl.sec.gov/dei/2025 http://xbrl.sec.gov/ecd/2025 false false